Comprehensive post-marketing safety evaluation of atezolizumab: A disproportionality analysis based on individual case safety reports in the FAERS - Yu Cui; Yuxuan Gao; Na Meng; Xiaojuan Li; Na Zhao; Lili Yu (PLoS ONE, 2026)